Blake Jennewein
@blaketarvy.bsky.social
ID Pharmacist 🦠 Boilermaker 🚂⬆️ Here for ID & CBB 🧫🏀
Reposted by Blake Jennewein
Evaluation of Changes in Staphylococcus and Enterococcus Resistance Following Reduced Restrictions on Daptomycin and Linezolid
✅ Just Accepted
🔗 https://bit.ly/4xnT82R
✅ Just Accepted
🔗 https://bit.ly/4xnT82R
August 29, 2026 at 10:25 PM
Evaluation of Changes in Staphylococcus and Enterococcus Resistance Following Reduced Restrictions on Daptomycin and Linezolid
✅ Just Accepted
🔗 https://bit.ly/4xnT82R
✅ Just Accepted
🔗 https://bit.ly/4xnT82R
Reposted by Blake Jennewein
More daptomycin and linezolid use—but no resistance penalty? 👀
After prescribing restrictions were eased, use increased. Yet across 19,160 isolates, investigators found no clinically relevant rise in resistance.
doi.org/10.1093/ofid...
#IDSky #AntimicrobialStewardship
After prescribing restrictions were eased, use increased. Yet across 19,160 isolates, investigators found no clinically relevant rise in resistance.
doi.org/10.1093/ofid...
#IDSky #AntimicrobialStewardship
Evaluation of Changes in Staphylococcus and Enterococcus Resistance Following Reduced Restrictions on Daptomycin and Linezolid
AbstractBackground. Daptomycin and linezolid may have more favorable safety and efficacy profiles compared to vancomycin and require less therapeutic monit
doi.org
August 26, 2026 at 7:41 PM
More daptomycin and linezolid use—but no resistance penalty? 👀
After prescribing restrictions were eased, use increased. Yet across 19,160 isolates, investigators found no clinically relevant rise in resistance.
doi.org/10.1093/ofid...
#IDSky #AntimicrobialStewardship
After prescribing restrictions were eased, use increased. Yet across 19,160 isolates, investigators found no clinically relevant rise in resistance.
doi.org/10.1093/ofid...
#IDSky #AntimicrobialStewardship